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Introduction
Organic synthesis of isoprenoids often results in low yields due to their complex structure. This makes production in large scale, by organic
synthesis economically unfeasible. Microbial production can easily be scaled to meet current demands and it is also an environmental benign
production method compared to organic synthesis. Thus it would be attractive to engineer a microorganism to produce high amounts of IPP
and other immediate prenyl precursors such as geranyl pyrophosphate, farnesyl pyrophosphate and geranylgeranyl pyrophosphate, thereby
establishing it as a microbial platform for heterologous expression of isoprenoid genes (see figure 1).
This project is focused on creating diversity within a lycopene producing S. cerevisiae strain by construction of gDNA-, cDNA-, and transposon-
libraries. The diversified population of S. cerevisiae clones will afterwards be screened using the isoprenoid molecule lycopene as a model
compound, hereby enabling the isolation of phenotypes producing higher amounts of isoprenoid. This will elucidate novel genetic targets for
increasing isoprenoid production in S. cerevisiae.
Future perspectives
When different genetic perturbations that increase the production of isoprenoids have been identified, the underlying metabolic mechanisms
will be sought identified through further analysis. We foresee that some perturbations will be straight forward to identify e.g. overexpression of
genes which are directly linked to isoprenoid precursor biosynthesis. The mechanisms which are harder to unravel will be the ones encoded by
ORFs with unassigned functions or regulatory mechanisms. Finally systematic combinations of the identified perturbations will be engineered
aiming at the construction of a S. cerevisiae platform for high titer production of isoprenoids.
Figure 2: Method for construction of gDNA library. In order to construct gDNA libraries it is essential to obtain randomly digested gDNA. This can be done by
treating high concentration gDNA with a 4 bp recognition endonuclease for a defined period of time. To find the correct amount of enzyme needed to obtain a partial
digest a dilution series is setup and the reactions with the desired size range is subsequently pooled wherefrom the size selected gDNA pieces are purified. The
random pieces are then ligated into an expression cassette (TEF1p-gDNA-CYC1t) in a single copy vector (pRS414TEF from Mumberg et al. 1994) followed by
transformation of ultra competent Escherichia coli cells. The final gDNA library is purified from the E. coli transformants. This library can be used for transformation
of Saccharomyces cerevisiae. This method is based on Jauert et al. 2005 and Liu 2002.
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Figure 3: A. Library screening based on lycopene colony coloration. The colonies exhibiting phenotypes with more intense red coloration compared to the wild type
are producing more lycopene than the wild type, hence the underlying genotype could result in a higher flux towards and through the mevalonate pathway hereby
increasing the precursor availability or in another way be beneficial for isoprenoid production. The transformants which shows intensified coloration can be further
analysed resulting in identification of the best candidates from which the underlying genotype can be elucidated. B. Biosynthetic pathway for converting farnesyl
pyrophosphate into lycopene. C. pSC203 plasmid for chromosomal integration of the CrtE-, CrtB-, and CrtI-gene from Erwinia herbicola under the control of the
TEF1-, PGK1-, and GDP-promoter respectively. D. UV-Vis absorption spectrum for lycopene. E. S. cerevisiae transformed with the pSC203 plasmid.
gDNA libraries
Transposon libraries cDNA libraries
Lycopene
OPP
GGPP
OPP
FPP
CRTE (GGPP synthetase)
CRTB (Phytoene synthetase)
PhytoeneCRTI (Phytoene desaturase)
pSC203
10573 bp
crtB
crtE
CRTI
Ter
URA3
APr
PGK1p
P TEF1
Promoter
P GPD
F1 ori
COLE1
ACT1t
ADH1t
T CYC
0
25
50
75
100
225 325 425 525
%
Wavelength (nm)
A B
C
D
E
Transformation
Colony screening
Micro titer screening
Shake flask characterization
Test fermentation
Data
Clones
Nature
S. cerevisiae cell factory
Transfer genes of interest
Carbon source
Fermentation
Pharmaceutical or precursors
Figure 1: Setup of S. cerevisiae as microbial production platform to produce secondary metabolites. By transferring the genes encoding the isoprenoids of interest
from its native host to a S. cerevisiae strain expressing them heterologous, it becomes possible to construct a microbial production platform for production of
isoprenoids, which could be used as pharmaceuticals or precursors instead of having to rely on extraction from native sources (thin curved arrow). By fermentation
of the constructed strain it will be possible to convert cheap carbon sources such as glucose into valuable products.
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